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Erratum
Erratum
Erratum: Jeter JM, Bowles TL, Curiel-Lewandrowski C, et al. Chemoprevention agents 
for melanoma: A path forward into phase 3 clinical trials. Cancer . 2019:125:18-44.
In this review, the name of Frank L. Meyskens, Jr., MD, of the Chao Family Comprehensive 
Cancer Center, University of California, Irvine, was inadvertently omitted from the list of 
authors. Dr. Meysken’s name should appear immediately following Svetomir N. Markovic, 
MD, PhD, in the list of authors.
The authors regret this error.
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